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Abstract
Background: Estimating the seroprevalence of HIV in a low risk population such as pregnant
women provides essential information for an effective implementation of AIDS control
programmes, and also for the monitoring of HIV spread within a country. Very few studies are
available from north India showing the current trend in HIV prevalence in the antenatal
population;which led us to carry outthis study at a tertiary care hospital in north India
Methods: Blood samples from pregnant women attending antenatal clinics at the All India Institute
of Medical Sciences, New Delhi were collected after informed consent and pre-test counseling. The
samples were tested for HIV antibodies as per the WHO guidelines, over a period of four years
from January 2003 to December 2006.
Results: Of the 3529 pregnant women tested in four years, 0.88% (CI 0.5 – 1.24) women were
found to be HIV seroreactive. Majority of the seroreactive pregnant women (41.9%) were in the
age group of 20–24 years followed by the 30–34 yrs (25.8%) and 25–29 years (22.6%) age group.
The mean age of the HIV positive women was 24.9 years (SD ± 1.49 yrs). The HIV seroprevalence
rates showed an increasing trend from 0.7% (CI 0.14 – 2.04) in 2003–2004 to 0.9% (CI 0.49 – 1.5)
in 2005–2006. This prevalence rate indicates concern, as Delhi and its adjoining states are
otherwise considered as 'low prevalence states'.
Conclusion: Seroprevalence of HIV infection was found to be increasing in the last four years
amongst pregnant women of North India. These findings are in contrast to the national projections.
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Background
India is categorized as a low prevalence nation for HIV
with a seroprevalence rate of less than 1% among the
adult population [1]. The country experienced a sharp
increase in the estimated number of HIV infections, from
a few thousand in the early 1990s to around 5.2 million
adults and children living with HIV/AIDS in 2005 [2]. In
view of our large population pool of one billion plus, a
mere 0.1 per cent increase in the prevalence rate will raise
the number of persons living with HIV by over half a mil-
lion. In India, the predominant mode of HIV transmis-
sion is through heterosexual contact [3], therefore,
unsuspecting women are at high risk of getting the infec-
tion.
The trend of new or incident infections, especially in
young people who have recently become sexually active,
is the most sensitive marker to track the course of the HIV
epidemic. Unfortunately, incidence is hard to measure
directly, but prevalence in young women is an indirect but
useful proxy [4]. Accordingly, HIV data from antenatal
women has been used to monitor trends in the general
population and to predict the seroprevalence in young
children [5,6]. In children below the age of 15 years
mother to child transmission is by far the most significant
route of transmission of HIV infection. While heterosex-
ual contact is the commonest mode of spread of the virus
in this country, perinatal transmission accounts for 4% of
the total HIV infection load in India [7]. As the HIV-posi-
tive women in India are increasing in number, conse-
quently the number of babies acquiring HIV infection in
the perinatal period is also expected to increase if the
infection goes undetected during pregnancy. Therefore,
screening of pregnant women at an early stage of preg-
nancy may help in prompt counseling and therapy,
thereby reducing the risk of transmission to the child.
To the best of our knowledge, only a few studies on HIV
prevalence in antenatal women are available from north
India, and infact none indicating the current trend in sero-
prevalence from this area. Hence, we undertook this study
to determine the rate and trends of HIV seroprevalence
among pregnant women attending antenatal clinics at the
All India Institute of Medical Sciences, New Delhi, which
is a tertiary care hospital of India and caters to patients
from most states of North India.
Methods
Setting
This study was carried out in the Microbiology Division of
the Department of Laboratory Medicine at the All India
Institute of Medical Sciences, New Delhi. This institute is
a tertiary care referral hospital.
Patients and period of study
Pregnant women registered at the antenatal clinics of this
hospital are routinely advised to undergo HIV and hepati-
tis B screening after pre-test counseling and informed con-
sent. Our laboratory caters these laboratory services to all
such patients, and tests are carried out as per the guide-
lines laid down by the National AIDS Control Organiza-
tion (NACO), India [8]. It is important to mention that
even though patients with other ailments are referred to
this hospital from all parts of India, the antenatal clinic
does not register pregnant women from other states,
except complicated cases. This policy is because obstetri-
cal services are freely available in all peripheral centers
also. While registering in the antenatal clinic, stay of more
than 5 years is considered an eligibility criteria. The results
were collected from all pregnant women tested in this lab-
oratory and no selection bias was observed. The findings
were analyzed over four years from January 2003 to
December 2006. All the tests were done after due patient
consent and in accordance with the institutional ethical
guidelines.
Specimen
Five ml venous blood sample was collected in a sterile
plain container from all pregnant women who came for
testing. Blood was allowed to clot for 30 minutes at room
temperature (25–30°C) and serum was separated after
centrifugation at low speed. The serum samples were then
stored at 4°C and were used within 48 hrs.
Serology
HIV antibodies were tested by the three ELISA/Rapid/Sup-
plemental tests protocol as per the guidelines laid down
by the World Health Organization (WHO Testing strategy
III) and positive test result disclosed only after post-test
counseling of the patients. Antibodies to HIV (1&2) were
tested initially with an ELISA kit (Adaltis™, Italy) and
repeatedly reactive samples were tested by a rapid test (Tri-
dot, J Mitra & Co, India). The reactive sera were further
confirmed by Western Blot (BioRad, USA).
Statistical analysis
The data were analyzed using the Chi-square tests. The
confidence interval for the prevalence estimates was calcu-
lated using STATA-9 statistical software.
Results
Data were collected and analyzed from a total of 3,529
pregnant women who were tested during the period of
four years from January 2003 to December 2006. The
mean age of the women attending antenatal clinics and
advised HIV screening was 26.4 years (95% CI = 1.82).
Majority of the pregnant women (41.7%) were in the age
group of 25–29 years followed by 20–24 years (34.6%),BMC Infectious Diseases 2007, 7:133 http://www.biomedcentral.com/1471-2334/7/133
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30–34 years (17.7%), 35 yrs or more (4.2%) and least in
the 15–19 yrs (1.6%) age group.
Overall, HIV-1 antibodies were detected in 0.88% (31 out
of 3,529) of the subjects [95% CI 0.5–1.24]. No pregnant
female was found seroreactive for HIV-2 antibodies.
Amongst the seropositive women, the majority (41.9%)
were aged 20–24 years followed by the age group of 30–
34 yrs (25.8%) and 25–29 yrs (22.6%). Only three (9.7%)
pregnant women below 20 years of age were detected HIV
positive while no woman above 34 years was found posi-
tive. The mean age of the HIV positive women was 24.9
years (SD ± 1.49 yrs). The youngest HIV positive female
was aged 18 years while the oldest was 32 years.
A year-wise analysis showed that in 2003 only 137 preg-
nant women were tested for HIV, most probably, because
the national policy of mandatory antenatal screening was
not in place at the institute by that time. After our institu-
tional guidelines were modified, the number of patients
screened for HIV increased to 289 in 2004, 1553 in 2005
and 1550 in 2006. The HIV seroprevalence rates showed
an increase from 0.7% (CI 0.14–2.04)in 2003–2004 to
0.9% (CI 0.49–1.5) in 2005–2006 [Table 1].
HIV seropositivity was highest at 1.2% (CI 0.7–2.02) in
the younger pregnant females in the 18–24 years of age-
group as compared to the older women (0.7%; CI 0.4–
1.17) of 25–34 years of age group [Table 2]. However, sta-
tistical analysis showed that this age-specific prevalence
was not significant (p > 0.5). The year-wise age-standard-
ized prevalence rates showed that while there was little
change in prevalence rates from 1.3% (CI 0.1–4.7) in
2003–2004 to 1.2% (CI 0.67–2.07) in 2005–2006 in the
15–24 years age group, a marginal rise in prevalence was
seen in the 25–34 yrs age group from 0.4% (CI 0.01–2.2)
in 2003–2004 to 0.7% (CI 0.41–1.26) in 2005–2006.
Discussion
India's socio-economic status, traditional social ills, cul-
tural myths on sexuality and a huge population of margin-
alized people make it extremely vulnerable to HIV/AIDS
[9]. Since the first case report in 1986 in Chennai in South
India, HIV has spread rapidly from urban to rural areas
and from high-risk groups to the general population [1-3].
In a country of over one billion population and 5.2 mil-
lion HIV positive adults in the 15–49 years age group,
India is now faced with multiple HIV-epidemics [10]. Het-
erosexual contact remains the major mode of transmis-
sion, thereby resulting in a growing population of HIV
infected women (38% in 2005) [2].
The present study, even though not representing the gen-
eral population, provides clear insight of an increasing
trend of HIV seroprevalence at the rate of 0.88% among
pregnant women in India. These findings have signifi-
cance because as per the official data from India's
National AIDS Control Organization (NACO) [1], Delhi
and the adjoining north-Indian states are categorized as
low prevalence areas for HIV. In these states the HIV prev-
alence rates among the vulnerable population groups are
reported to be below 5% and in women attending antena-
tal clinics less than 1%. Only the states of Maharashtra,
Tamil Nadu, Manipur, Andhra Pradesh, Karnataka and
Nagaland are categorized into high prevalence states
where the HIV seroprevalence is more than 1% in women
attending antenatal clinics. The NACO sentinel surveil-
lance data for the state of Delhi reported HIV prevalence
of 0.25% in 2003, 0.38% in 2004 [1] and 0.25% in 2005
[10]. Therefore; our data indicate a different scenario
where the prevalence rate was found to be significantly
higher (0.88%) than the NACO data. One reason for this
difference between the data of NACO and ours could be
surveillance methodologies. While ours was a hospital
based study over a period of 4 years, the NACO utilizes
sentinel surveillance system. Both the systems have their
own limitations. Beside the data from NACO, as there is
no other study reported from this part of India, for com-
parison of our findings.
Our results also become significant because the HIV sero-
prevalence rate has reached almost 0.9% in pregnant
women which is very close to the cut-off value of 1% used
to categorize a state as low or high prevalence area. This
finding of rising HIV seropositivity rate in antenatal
women in an area previously considered 'low prevalence
region' of India, could indicate a increasing trend of HIV
transmission in the general population of this region, in
contrast to the claims of 'a contained epidemic of HIV in
India' by national agencies. While analyzing the trend of
Table 1: Year-wise prevalence rates of HIV in pregnant women at a tertiary care centre in north-India
Year Total tested HIV positives % positivity (95% CI)
2003–2004 426 3 0.70 (0.14–2.04)
2005 1553 14 0.90 (0.49–1.5)
2006 1550 14 0.90 (0.49–1.5)
Total 3529 31 0.88 (0.5–1.24)BMC Infectious Diseases 2007, 7:133 http://www.biomedcentral.com/1471-2334/7/133
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seroprevalence, we found a rise in the HIV seroprevalence
rate from 0.7% in 2003–2004 to 0.9% in 2005–2006.
Even though the change in prevalence rate was statistically
insignificant (p > 0.5) due to non-comparable number of
women included in the first and fourth year of the study,
the trend indicated concern.
The prevalence of HIV seropositivity was highest (1.2%)
in the newly sexually active pregnant females belonging to
the 18–24 years age-group. These findings are similar to a
study among antenatal women in western India by Ukey
et al [11] in which the authors found that HIV seropreva-
lence increased from 1.24% in 2002–2003 to 1.45% in
the year 2003–2004. This study also reported that the
most affected age group was 18–24 years followed by the
older age groups [11]. It has been well substantiated that
most women in India are infected with HIV through their
husbands [3,12]. This holds true for both rural as well as
urban settings. Our results showed only a marginal
decrease in prevalence rates in young, newly sexually
active females (15–24 yrs) from 1.3% in 2003–04 to 1.2%
in 2005–2006. This slight dip in prevalence could be a
result of effective awareness programmes and education
regarding HIV especially in young adults after the imple-
mentation of National AIDS control programme (NACP-
II, 1999–2006). The NACP II sought to shift focus from
raising awareness to changing behavior through interven-
tions in high risk groups. Intervention programmes such
as HIV awareness and safe sex education are usually
focused on young adults and our data show a favorable
impact of such programmes. Therefore, it is understanda-
ble why over a period of 4 years the HIV seroprevalence
showed a decline in young adult mothers. Since the
impact of such programmes will have marginal effect in
older couples, our data were on expected lines. Even Pal-
likadavath et al [13] showed that HIV awareness among
north Indian married women was higher in the 15–24
years age group as compared to older women. In a recent
study published by Kumar et al [4], a decreasing trend in
HIV prevalence has been reported in South Indian preg-
nant women aged 15–24 years from 1.7% to 1.1% within
a period of four years from 2000 to 2004 after antenatal
counseling and awareness programmes were initiated and
increasing propagation of safe sex was started. These
awareness programmes have difficult pervasiveness in
older women and hence, it is not surprising that seroprev-
alence rates continued to increase over the study period. It
is also possible that these women were infected in past
(not incidence rate) but were detected during the study
period when the HIV testing for these women was made
available. Moreover, these women have a higher repro-
ductive history with higher rates of exposure to risk factors
like surgical interventions during successive pregnancies
and higher risk of sexually transmitted infections (STI's).
This has been further compounded by lower levels of edu-
cation, low access to health care facilities and higher rates
of promiscuous activities of their husbands before the
aggressive awareness programmes were launched. It is
well known that women are less likely to visit a public
antenatal clinic if they are older, have high parity, are illit-
erate, or are poor [5,6] making this a vulnerable group.
Lastly, in our study, we found only 149 pregnant women
in the age group of 35 yrs and above, who were tested for
HIV over a period of four years of study. Though we could
not find any HIV positive pregnant women in this age
group, yet this number of pregnant women is very small
to comment upon.
Conclusion
Our study indicates an increasing trend of HIV prevalence
in northern India. Even though, our study population is
not representative of whole India because of ours being a
hospital based study with limited sample size, the data
show an increasing trend of HIV spread in housewives and
pregnant mothers. This will directly transform into a high
perinatal transmission and a reciprocal increase in pediat-
ric AIDS cases. Therefore, it may be recommended that
even though the curative treatment for HIV is not availa-
ble at present we can minimize, if not prevent, the pediat-
ric HIV infection by early screening of pregnant mothers
for HIV followed by perinatal short term chemotherapy,
safe delivery practices and modified infant feeding.
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Table 2: Age-standardized year-wise trends in HIV-prevalence in pregnant women at a tertiary care hospital in north India
Overall 2003 & 2004 2005 & 2006
Age (yrs) Total 
Tested
HIV +ve % positives (95% CI) Total 
Tested
HIV +ve % positives (95% CI) Total 
Tested
HIV +ve % positives (95% CI)
15–24 1281 16 1.2* (0.7–2.02) 151 2 1.3* (0.1–4.7) 1130 14 1.2* (0.67–2.07)
25–34 2099 15 0.7 (0.4–1.17) 250 1 0.4 (0.01–2.2) 1849 14 0.7 (0.41–1.26)
*The HIV prevalence rates were higher in the 15–24 year age-group, but not significant (p > 0.5)Publish with BioMed Central    and   every 
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